病例8：合并急性消化道出血的胃胃肠间质瘤治疗过程中肿瘤复发并进展
被引量：1
摘要
男性，65岁。主诉：黑粪3d，左侧腹痛2d。患者2011年10月12无明显诱因出现排黑粪伴腹痛．检查血红蛋白：68g／L，急诊收治入院。入院后行全腹增强CT检查，脾胃间巨大占位，见图1，考虑间叶源性肿瘤伴出血。
出处
《中华胃肠外科杂志》
CAS
CSCD
北大核心
2017年第9期1083-1084,共2页
Chinese Journal of Gastrointestinal Surgery
二级参考文献20
-
1Siekliek JK, Lopez NE. Optimizing Surgical and Imatinib Therapy for the Treatment of Gastrointestinal Stromal Tumors [J]. J Gastrointest Surg, 2013,17: 1997-2006.
-
2Kee D, Zalcberg JR. Current and emerging strategies for the management of imatinib-refractory advanced gastrointestinal stromal tumors[J]. Ther Adv Med Oncol, 2012,4:255-270.
-
3Rutkowski P, Gronchi A, Hohenberger P, et al. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST) : the EORTC STBSG experience [ J ]. Ann Surg Oncol, 2013,20: 2937-2943.
-
4Eisenberg BL, Harris J, Blanke CD, et al. Phase lI trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665 [J]. J Surg Oncol, 2009,99 : 42-47.
-
5Wang D, Zhang Q, Blanke CD, et al. Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors :long-term follow-up results of Radiation Therapy Oncology Group 0132[J]. Ann Surg Oncol, 2012,19:1074- 1080.
-
6Blesius A, Cassier PA, Bertucci F, et al. Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in theprospective BFR14 trial[J~. BMC Cancer, 2011,11:72.
-
7Rutkowski P, Nowecki Z, Nyckowski P, et al. Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate [ J ]. J Surg Oncol, 2006,93 : 304-311.
-
8DeMatteo RP, Maki RG, Singer S, et al. Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor[J]. Ann Surg, 2007, 245 : 347-352.
-
9Gronchi A, Fiore M, Miselli F, et al. Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST[J]. Ann Surg, 2007, 245 : 341-346.
-
10Mussi C, Ronellenfitsch U, Jakob J, et al. Post-imatinib surgery in advanced/metastatic GIST: is it worthwhile in all patients? [J]. Ann Oncol, 2010,21:403-408.
共引文献5
-
1高晓东,薛安慰,方勇,束平,李鹤,凌佳倩,王力,侯英勇,沈坤堂,秦净,孙益红,秦新裕.靶向药物联合手术治疗复发转移胃肠间质瘤患者的疗效分析[J].中华胃肠外科杂志,2016,19(11):1282-1285. 被引量：6
-
2崔亚,姜礼双,卜平.食管胃肠道间质瘤治疗进展[J].肿瘤防治研究,2017,44(4):303-307. 被引量：4
-
3雷程,刘翔,葛磊,王琦三,王海江.胃肠间质瘤术后154例预后分析[J].肿瘤基础与临床,2017,30(4):300-303. 被引量：1
-
4郭磊,郑坚江,刘跃全,苏福增.腹腔镜联合胃镜治疗胃间质瘤的疗效分析[J].腹腔镜外科杂志,2018,23(4):286-289. 被引量：7
-
5王玮,梁小波.复发转移性胃肠间质瘤的治疗概述[J].中华临床医师杂志（电子版）,2016,10(15):2336-2340.
同被引文献5
-
1曹晖,汪明.胃肠间质瘤诊断与治疗的新挑战——从循证医学到精准医学的思考与实践[J].中华胃肠外科杂志,2016,19(1):17-21. 被引量：5
-
2刘秀峰,李健,李勇,周永建,沈琳,卢辉山,秦叔逵.伊马替尼一线治疗国人晚期胃肠间质瘤获益人群特征分析:多中心8年随访数据[J].临床肿瘤学杂志,2016,21(2):97-105. 被引量：4
-
3Ntahompagaze,The0phile,吴海福,施晨晔,焦妲,楼文晖.腹腔镜与开腹手术治疗胃肠间质瘤的疗效分析及不同危险度对患者预后的影响[J].中华消化外科杂志,2016,15(9):882-887. 被引量：35
-
4曹晖,汪明.靶向药物治疗时代的柳叶刀——手术在晚期胃肠间质瘤治疗中的地位[J].中华胃肠外科杂志,2016,19(11):1211-1216. 被引量：13
-
5冯兴宇,胡伟贤,张鹏,邱海波,周永建,赖斌,陈韬,郑国良,熊文俊,王巍,刘秀峰,尹源,万相斌,张子通,赵曦,李智,张波,王伟,赵岩,李国新,李红浪,黄昌明,周志伟,陶凯雄,李勇.十二指肠胃肠间质瘤外科治疗多中心临床分析[J].中国实用外科杂志,2018,38(5):535-540. 被引量：3
